CBP Mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter

Molecular and Cellular Biology

Volumn 32, Issue 2, 2012, Pages 569-575

  Pradhan, Madhumita ^a   Baumgarten, Sarah C ^a   Bembinster, Leslie A ^a   Frasor, Jonna ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC3 PROTEIN; ESTROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE CBP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDES AND PROTEINS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL; CELL STRAIN MCF 7; CELL SURVIVAL; CYTOKINE RESPONSE; ESTROGEN RESPONSIVE ELEMENT; HISTONE ACETYLATION; INFLAMMATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; TUMOR GROWTH;

ACETYLATION; BREAST NEOPLASMS; CELL LINE, TUMOR; CREB-BINDING PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS;

EID: 84856782680     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05869-11     Document Type: Article

References (53)

1. Adamson AD, et al. 2008. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling. Endocrinology 149:687-694.
2. Bodine PV, Harris HA, Komm BS. 1999. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Endocrinology 140:2439-2451.
3. Brower-Toland B, et al. 2005. Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes. J. Mol. Biol. 346:135-146.
4. Cakouros D, et al. 2001. A NF-kappa B/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocytemacrophage colony-stimulating factor transgene. J. Immunol. 167: 302-310.
5. Carroll JS, et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43.
6. Carroll JS, et al. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38:1289-1297.
7. Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA. 2010. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58:93-102.
8. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. 2006. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147:4831-4842.
9. Chen LF, Mu Y, Greene WC. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21: 6539-6548.
10. Chu S, Nishi Y, Yanase T, Nawata H, Fuller PJ. 2004. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol. 18:1919-1928.
11. Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78:273-304.
12. Clarke DL, et al. 2010. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREBbinding protein. J. Biol. Chem. 285:29101-29110.
13. Cvoro A, et al. 2006. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol. Cell 21:555-564.
14. Feldman I, Feldman GM, Mobarak C, Dunkelberg JC, Leslie KK. 2007. Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am. J. Obstet. Gynecol. 196:394.e1-394.e13.
15. Frasor J, et al. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574.
16. Frasor J, et al. 2009. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res. 69:8918-8925.
17. Frasor J, Weaver AE, Pradhan M, Mehta K. 2008. Synergistic upregulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. Endocrinology 149: 6272-6279.
18. Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. 2004. Anatomy of the estrogen response element. Trends Endocrinol. Metab. 15: 73-78.
19. Hah N, et al. 2011. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145:622-634.
20. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. 2000. The role of CBP in estrogen receptor cross-talk with nuclear factorkappaB in HepG2 cells. Endocrinology 141:3403-3411.
21. Heldring N, et al. 2011. Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol. Endocrinol. 25:564-574.
22. Holloway AF, Rao S, Chen X, Shannon MF. 2003. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197:413-423.
23. Holloway JN, Murthy S, El-Ashry D. 2004. A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptoralpha down-regulation in breast cancer cells: the role of nuclear factorkappaB. Mol. Endocrinol. 18:1396-1410.
24. Hong SY, et al. 2000. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 275:18022-18028.
25. Hua B, et al. 2006. A splice variant of stress response gene ATF3 coun-teracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator. J. Biol. Chem. 281: 1620-1629.
26. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. 2011. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43:27-33.
27. Jakacka M, et al. 2002. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16:2188-2201.
28. Kalaitzidis D, Gilmore TD. 2005. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 16:46-52.
29. Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL. 2006. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 20:1479-1493.
30. King AE, et al. 2010. An additive interaction between the NFkappaB and estrogen receptor signalling pathways in human endometrial epithelial cells. Hum. Reprod. 25:510-518.
31. Kininis M, et al. 2007. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 27:5090-5104.
32. Klinge CM, Jernigan SC, Smith SL, Tyulmenkov VV, Kulakosky PC. 2001. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell Endocrinol. 174:151-166.
33. Kushner PJ, et al. 2000. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74:311-317.
34. Lalmansingh AS, Uht RM. 2008. Estradiol regulates corticotropinreleasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-alpha and -beta recruitment to a 3′,5′-cyclic adenosine 5′-monophosphate regulatory region of the proximal crh promoter. Endocrinology 149:346-357.
35. Lin CY, et al. 2007. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 3:e87.
36. Mahmoodzadeh S, et al. 2009. Nuclear factor-kappaB regulates estrogen receptor-alpha transcription in the human heart. J. Biol. Chem. 284: 24705-24714.
37. Mao C, et al. 2008. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. J. Biol. Chem. 283:12819-12830.
38. Mason CE, et al. 2010. Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements. Nucleic Acids Res. 38:2355-2368.
39. McDevitt MA, et al. 2008. New insights into the classical and nonclassical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice. Mol. Cell Endocrinol. 290:24-30.
40. Ndlovu N, et al. 2009. Hyperactivated NF-κB and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell. Biol. 29:5488-5504.
41. Nettles KW, et al. 2008. CBP is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol. Endocrinol. 22:263-272.
42. Nissen LJ, Gelly JC, Hipskind RA. 2001. Induction-independent recruitment of CREB-binding protein to the c-fos serum response element through interactions between the bromodomain and Elk-1. J. Biol. Chem. 276:5213-5221.
43. Pradhan M, Bembinster LA, Baumgarten SC, Frasor J. 2010. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF-κB cooperativity at adjacent response elements. J. Biol. Chem. 285: 31100-31106.
44. Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
45. Rubio MF, et al. 2006. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:1367-1377.
46. Ryser S, Massiha A, Piuz I, Schlegel W. 2004. Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter. Biochem. J. 378:473-484.
47. Safe S, Kim K. 2008. Non-classical genomic estrogen receptor (ER)/ specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 41:263-275.
48. Sorlie T, et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98:10869-10874.
49. Sorlie T, et al. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 100:8418-8423.
50. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO, III. 2000. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ. Res. 87: 1006-1011.
51. Stanculescu A, et al. 2010. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner. Horm. Cancer 1:127-135.
52. Vega VB, et al. 2006. Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites. Genome Biol. 7:R82.
53. Wissink S, van der Burg B, Katzenellenbogen BS, van der Saag PT. 2001. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol. Endocrinol. 15:543-552.